Compare Revvity Inc (RVTY) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Toyota Motor Corp — how do they compare? Revvity Inc trades at $117.6 (market cap $12.91B), while Toyota Motor Corp trades at $189.35 (market cap $221.79B). The key difference: Toyota Motor Corp is far larger — about 17.2× Revvity Inc's market cap, and Toyota Motor Corp pays the higher dividend (3.3%). Which is the better fit depends on your goals.
| RVTY | TM | |
|---|---|---|
Market Cap | $12.91B | $221.79B |
Sector | Technology | Consumer Cyclical |
52-Week High | $117.75 | $248.29 |
52-Week Low | $82.26 | $166.50 |
Enterprise Value | $15.23B | $414.06B |
Dividend Yield | 0.24% | 3.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $116.10, up 0.07% on the day, with a bullish technical signal and strong earnings beats in recent quarters. The company reported Q2 2026 EPS of $1.41, surpassing the $1.21 estimate, and raised its full-year outlook due to robust diagnostics demand. Revenue remains steady around $2.9 billion, with a net income margin of 8.16%. Analyst consensus is a Buy with a $120.50 price target, and recent news highlights product launches like the SuperFlex prenatal system and high-throughput TB testing platform.
The outlook for RVTY is positive, supported by earnings momentum and strategic innovations, but investors face risks from high valuation multiples and competitive pressures in the healthcare sector. The stock's proximity to its consensus target suggests limited near-term upside, requiring careful monitoring of execution against raised guidance.
Toyota Motor trades at $188.22, down 0.3% over 24 hours, with a bullish technical signal and strong fundamentals including a low P/E of 8.53 and consistent earnings beats. Recent news highlights a major vehicle recall and mixed quarterly results, with revenue growth offset by cost pressures.
The outlook is cautiously optimistic given attractive valuation and hybrid vehicle strength, but risks include recall costs, China sales weakness, and macroeconomic headwinds. Analyst consensus leans Hold, reflecting balanced growth prospects against near-term challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
